NYSE$USNA
USANA Health Sciences Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
USANA's first quarter net sales and diluted EPS were reported.
USANA Health Sciences reported a decrease in net sales and diluted EPS compared to Q1 2022, but an increase sequentially. Net sales were $248 million and diluted EPS was $0.95. The company has raised the lower end of its net sales and earnings per share guidance for fiscal year 2023.
- Net sales were $248 million, a 9% decrease compared to Q1 2022 but a 9% increase sequentially.
- Diluted EPS was $0.95, a 17% decrease compared to Q1 2022 but a 44% increase sequentially.
- Operating cash flow was $13 million for the quarter.
- Fiscal year 2023 net sales and diluted EPS guidance updated to $875 to $950 million and $2.40 to $3.30, respectively.
Headline financials
Revenue & EPS history
USANA · Revenue · Quarterly
$248M
Forward guidance
The company is raising the lower end of its net sales and earnings per share outlook for fiscal year 2023 due to the performance in the first quarter.
Tailwinds
- Sales during the first few weeks of the quarter benefited by approximately $12 million due to higher demand for several of our health products in China.
- Sales benefited by an estimated $13 million in customer purchasing activity ahead of announced price increases.
- Revised consolidated net sales guidance is $875 - $950 million.
- Revised diluted EPS guidance is $2.40 - $3.30.
- The company is raising the lower end of its guidance range for both net sales and earnings per share as a result of the performance in the first quarter.
Headwinds
- Fiscal 2023 outlook continues to reflect a wider range due to the continued uncertainty surrounding the operating and geopolitical environment around the world.
- Net sales decreased by 9% compared to Q1 2022.
- Diluted EPS decreased by 17% compared to Q1 2022.
- Active Customers decreased by 11% vs. Q1 2022
- The company's results could differ materially from those projected in forward-looking statements, which involve a number of risks and uncertainties.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
+2.3%
Avg return
Earnings day
+2.0%
Avg return
5 days after
+1.6%
Avg return
30 days after
58%
37 / 64 earnings
Positive
+39.2%
Q2 2015
Best reaction
-24.1%
Q4 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.3% | -9.7% | -7.0% | |
| Q3 2025 | -1.6% | -2.8% | -6.0% | |
| Q2 2025 | +4.1% | +0.8% | +1.5% | |
| Q1 2025 | +4.9% | +13.6% | +21.4% | |
| Q4 2024 | +3.9% | -6.2% | -13.1% | |
| Q3 2024 | +4.4% | +5.0% | +12.3% | |
| Q2 2024 | -3.7% | -7.7% | -14.6% | |
| Q1 2024 | +6.0% | +6.0% | +8.7% | |
| Q4 2023 | +7.1% | +9.6% | +4.6% | |
| Q3 2023 | -16.7% | -17.7% | -13.8% | |
| Q2 2023 | +6.5% | +2.1% | -0.3% | |
| Q1 2023 | +4.9% | +2.5% | -4.4% | |
| Q4 2022 | +4.7% | +4.0% | +2.4% | |
| Q3 2022 | -0.2% | -3.0% | -6.5% | |
| Q2 2022 | +1.1% | +1.4% | -0.5% | |
| Q1 2022 | -3.6% | -2.6% | -10.4% | |
| Q4 2021 | -8.4% | -5.2% | -10.1% | |
| Q3 2021 | -8.0% | -3.4% | +1.3% | |
| Q2 2021 | -2.3% | -6.8% | -6.9% | |
| Q1 2021 | -7.7% | -6.4% | +9.4% | |
| Q4 2020 | +15.7% | +6.3% | +16.4% | |
| Q3 2020 | +5.1% | +10.7% | -3.5% | |
| Q2 2020 | -6.4% | -12.4% | -8.8% | |
| Q1 2020 | +17.5% | +25.2% | +23.8% | |
| Q4 2019 | +25.3% | +28.1% | +15.7% | |
| Q3 2019 | +11.5% | +4.8% | +1.8% | |
| Q2 2019 | +0.3% | +6.1% | +5.7% | |
| Q1 2019 | +9.4% | +2.2% | -12.9% | |
| Q4 2018 | -11.4% | -6.5% | -18.1% | |
| Q3 2018 | +3.5% | +2.7% | +13.0% | |
| Q2 2018 | +23.9% | +18.9% | +19.0% | |
| Q1 2018 | +11.6% | +10.3% | +22.2% | |
| Q4 2017 | +5.6% | +7.0% | +14.4% | |
| Q3 2017 | +12.5% | +9.7% | +10.1% | |
| Q2 2017 | -10.0% | -11.2% | -7.5% | |
| Q1 2017 | +6.5% | +13.4% | +16.4% | |
| Q4 2016 | -11.6% | -8.9% | -8.9% | |
| Q3 2016 | -8.2% | -11.5% | -13.6% | |
| Q2 2016 | +11.6% | +8.2% | +8.4% | |
| Q1 2016 | +6.2% | — | — | |
| Q4 2015 | -24.1% | — | — | |
| Q3 2015 | -11.6% | — | — | |
| Q2 2015 | +39.2% | — | — | |
| Q1 2015 | +19.2% | — | — | |
| Q4 2014 | -6.6% | — | — | |
| Q3 2014 | +26.5% | — | — | |
| Q2 2014 | -7.8% | — | — | |
| Q1 2014 | -15.2% | — | — | |
| Q4 2013 | +18.8% | — | — | |
| Q3 2013 | -9.6% | — | — | |
| Q2 2013 | -13.3% | — | — | |
| Q1 2013 | +8.1% | — | — | |
| Q4 2012 | +5.8% | — | — | |
| Q3 2012 | +1.7% | — | — | |
| Q2 2012 | +5.4% | — | — | |
| Q1 2012 | +2.0% | — | — | |
| Q4 2010 | -4.2% | — | — | |
| Q4 2011 | -4.2% | — | — | |
| Q3 2011 | -5.4% | — | — | |
| Q2 2011 | -0.3% | — | — | |
| Q1 2011 | -0.3% | — | — | |
| Q3 2010 | -2.0% | — | — | |
| Q2 2010 | +4.3% | — | — | |
| Q1 2010 | +4.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro